Related by context. All words. (Click for frequent words.) 69 osteosarcomas 68 premalignant lesions 68 nonmelanoma skin cancers 68 ductal cancer 68 renal cell carcinomas 68 colorectal carcinoma 67 gastric cancers 67 premalignant 67 prostate cancer CaP 67 node metastases 67 tumoral 67 acoustic neuroma 67 choroidal melanoma 66 meningiomas 66 intestinal metaplasia 66 MALT lymphoma 66 adenocarcinomas 66 pancreatic adenocarcinoma 66 basal cell carcinomas 66 squamous cell carcinoma SCC 66 basal cell carcinoma BCC 66 invasive ductal 66 basal cell skin 65 epithelial tumors 65 cutaneous melanoma 65 renal carcinoma 65 adenoma 65 frequently benign tumor 65 colorectal tumors 65 GISTs 65 neovascular 65 ADPKD 65 salivary gland tumors 65 hyperplastic 65 proliferative diabetic retinopathy 65 hamartomas 65 neovascular AMD 65 precursor lesions 65 serous ovarian cancer 65 Squamous 65 acoustic neuromas 65 mucinous 65 choroidal neovascularization 64 hepatocellular carcinoma 64 malignant growths 64 paragangliomas 64 endometrial cancers 64 HNSCC 64 metachronous 64 liver metastasis 64 carcinomas 64 bladder cancers 64 mesotheliomas 64 rebleeding 64 endometrial hyperplasia 64 nodal metastasis 64 lymphatic tissue 64 pheochromocytoma 64 colorectal adenoma 64 Sjögren syndrome 64 cisplatin resistant 64 Papillary 64 cirrhotic 64 metastatic lesions 64 testicular cancers 64 testicular tumors 64 neoplastic lesions 64 hyperplastic polyps 64 metastases 64 axillary lymph nodes 64 hepatocellular carcinoma HCC 64 invasive carcinoma 64 postoperative delirium 63 anterior uveitis 63 chronic periodontitis 63 prostate adenocarcinoma 63 pituitary adenomas 63 GNAQ 63 NMIBC 63 POAG 63 nasopharyngeal carcinoma 63 intravitreal injections 63 breast carcinoma 63 neurofibromas 63 neoplasia 63 meningioma 63 advanced adenomas 63 familial ALS 63 neoplasm 63 prostate carcinoma 63 renal tumors 63 histological subtype 63 oral squamous cell 63 transitional cell carcinoma 63 gastric carcinoma 63 MGUS 63 colorectal adenomas 63 solar keratosis 63 malignant lesions 63 distant metastasis 63 paraganglioma 63 basal cell nevus syndrome 63 distal colon cancer 63 adenomatous polyps 63 carcinoid tumor 63 histologic subtype 63 colorectal neoplasms 63 lobular cancer 62 advanced adenoma 62 medullary thyroid cancer 62 HBeAg negative 62 Hurthle cell 62 neuroblastomas 62 thyroid carcinoma 62 breast carcinomas 62 chronic rhinosinusitis 62 pancreatic ductal adenocarcinoma 62 carcinoids 62 GIST tumors 62 proliferative retinopathy 62 HbF 62 atypical hyperplasia 62 cell carcinomas 62 squamous cell lung cancer 62 nonmelanoma skin cancer 62 cervical lymph nodes 62 squamous cell cancers 62 gastric adenocarcinoma 62 CIN3 62 endophthalmitis 62 pulmonary metastases 62 microbleeds 62 glaucomatous 62 leiomyomas 62 lymph node metastases 62 brain tumors 62 malignant lymphoma 62 atherosclerotic lesions 62 ependymomas 62 esophageal cancers 62 PAOD 62 neoplasias 62 colorectal cancer CRC 62 urothelial carcinoma 62 ductal adenocarcinoma 62 papillary renal cell carcinoma 62 HER2 positive cancers 62 endometrial carcinoma 62 malignant neoplasm 62 oropharyngeal cancer 62 ovarian carcinoma 62 locoregional recurrence 62 BRCA1 mutation carriers 62 NF1 62 benign neoplasms 62 gliomas 62 lobular breast cancer 62 lung nodules 62 transthyretin 62 ependymoma 62 metastatic gastric 62 hypertrophic scars 62 PCa 62 cardiac dysfunction 62 recurrent glioblastoma multiforme 62 sarcomatoid 62 lymph node metastasis 62 EGFR receptor 61 HER2 overexpression 61 precancerous cervical 61 lung tumors 61 axilla 61 lung metastasis 61 parotid gland tumors 61 pleomorphic 61 carcinoid 61 geographic atrophy 61 malignant pancreatic 61 lichen planus 61 malignant transformation 61 varices 61 extracranial 61 precancerous condition 61 localized renal 61 squamous cell carcinomas 61 urothelial cancer 61 lung carcinomas 61 esophageal squamous cell carcinoma 61 pre cancerous growths 61 cervical neoplasia 61 squamous cell cancer 61 CMV infection 61 variceal bleeding 61 breast cancer metastasis 61 basal cell cancers 61 tumors 61 neovascularization 61 pulmonary metastasis 61 malignant tumors 61 papillomas 61 lobular carcinoma 61 neoplasms 61 Helicobacter pylori infection 61 squamous cell 61 ductal breast cancer 61 percutaneous biopsy 61 colorectal adenocarcinoma 61 neuroendocrine tumors 61 operable breast cancer 61 lung metastases 61 chemoresistant 61 hemorrhagic complications 61 malignancy 61 PCNSL 61 embryonal rhabdomyosarcoma 61 cancerous lesions 61 Prostatitis 61 amyloid deposition 61 papillary 61 breast endometrial 61 gastrointestinal cancers 61 invasive lobular 61 intraoperative complications 61 Hashimoto thyroiditis 61 adenocarcinoma 61 thromboembolic events 61 periodontitis 61 nonmetastatic 61 carcinoma 61 skeletal metastases 61 atrophic gastritis 61 uterine cancers 61 leiomyoma 61 hypermethylated 61 nonmelanoma 61 tonsillar 61 telangiectasia 61 pancreatic carcinoma 61 distant metastases 61 immunocompetent 61 precancer 61 BRCA2 mutation carriers 61 pheochromocytomas 61 CP CPPS 61 BRAF V#E mutation 61 mtDNA mutations 61 neuroblastoma tumor 61 N. gonorrhoeae 60 dysplastic 60 benign polyps 60 temporal arteritis 60 CIN3 + 60 BRAF protein 60 gallstone disease 60 biochemical recurrence 60 systemic scleroderma 60 bacteriuria 60 glioma 60 colorectal polyps 60 adenomatous 60 thyroid nodules 60 histologically 60 choroidal neovascularization CNV 60 intravenous bisphosphonates 60 BRAF mutation 60 Candida infection 60 BRAF mutations 60 familial pancreatic cancer 60 metastatic lymph nodes 60 ALCL 60 metastatic tumors 60 macular holes 60 ALK mutations 60 melanoma lesions 60 soft tissue sarcomas 60 Squamous cell 60 monogenic 60 nonsmall cell lung cancer 60 HER2 amplification 60 ductal lobular 60 oropharyngeal 60 S. aureus infection 60 adrenalectomy 60 gastric varices 60 lipomas 60 cardioembolic stroke 60 malignant lymphomas 60 pre cancerous lesion 60 Gorlin syndrome 60 Adenomas 60 mutated K ras 60 Hepatocellular Carcinoma HCC 60 basal cell carcinoma 60 neurofibroma 60 leukaemias 60 retinal vein occlusion 60 untreated celiac disease 60 nodular melanoma 60 hamartoma 60 ASCUS 60 IDH1 mutation 60 thyroid nodule 60 micrometastases 60 nevi 60 choroid 60 axillary node 60 KRAS mutations occur 60 schwannomas 60 sentinel node 60 localized prostate 60 Barrett esophagus BE 60 Cryptococcus neoformans 60 esophagogastric junction 60 cholangiocarcinoma 60 situ LCIS 60 de ath 60 malignant prostate 60 microbial keratitis 60 demyelinating 60 meningeal 60 hypervascular 60 angiosarcoma 60 atherosclerotic disease 60 pancreatic prostate 60 colorectal gastric 60 Waldenstrom macroglobulinemia 60 Cholangiocarcinoma 60 genital herpes infections 60 elevated IOP 60 WT1 60 neuroendocrine carcinoma 60 infantile hemangiomas 60 metaplasia 60 micronuclei 60 C. pneumoniae 60 mesenteric 60 neuroblastoma tumors 60 pT2 60 papillary carcinoma 60 oligodendrogliomas 60 sporadic ALS 60 Brain metastases 60 Leukemias 60 Leydig cell 60 #q# deletion 60 perianal 60 axillary lymph node dissection 60 grade cervical intraepithelial 60 p# mutations 60 LRP5 60 BCR ABL mutations 60 anal cancers 60 oesophageal adenocarcinoma 60 nutlin 3a 60 ductal 60 colorectal tumor 60 hyperplasia 60 advanced hepatocellular carcinoma 60 neovascularisation 60 GBM tumors 60 EGFR mutations 60 osteoid 60 liver metastases 60 sCJD 60 HER2 expression 60 malignant polyps 60 seminoma 60 leukoplakia 60 endometrioid 60 endobronchial 60 T1DM 60 completely resected 60 chlamydial infection 60 urolithiasis 60 colorectal polyp 60 malignant ovarian 59 medulloblastomas 59 tumor recurrence 59 radioiodine therapy 59 metastatic neuroendocrine tumors 59 seminomas 59 conjunctival hyperemia 59 CMV infections 59 genital ulcers 59 epithelioid 59 ruptured aneurysms 59 BRCA1 mutations 59 papillary thyroid cancer 59 candidemia 59 germline mutations 59 vitreous floaters 59 gastrointestinal perforation 59 KRAS oncogene 59 ductal carcinomas 59 ANCA associated 59 kidney urologic 59 molecular abnormalities 59 acute leukemias 59 cancerdefine 59 bone metastasis 59 CIN2 + 59 invasive ductal carcinoma 59 astrocytomas 59 FDG uptake 59 EGFR mutation positive 59 malignant brain 59 underwent resection 59 antiangiogenic therapy 59 arterial calcification 59 herpetic 59 adenomas 59 intrahepatic 59 hepatic metastases 59 Chlamydia trachomatis infection 59 Basal cell 59 ocular melanoma 59 genitourinary tract 59 STAT4 59 ischemic lesions 59 neoplastic 59 BRAF gene 59 microvascular disease 59 intraepithelial neoplasia 59 papillary thyroid carcinoma 59 BMPR2 59 postoperative AF 59 nonalcoholic steatohepatitis NASH 59 Endometrial 59 microvascular complications 59 cisplatin chemotherapy 59 CDH1 59 lesional 59 childhood leukemias 59 essential thrombocythemia 59 Aspergillus infections 59 colorectum 59 mammary tumors 59 varicella infection 59 Legg Calvé Perthes disease 59 glioma tumors 59 hepatocellular cancer 59 differentiated thyroid 59 splenic 59 Squamous cell carcinomas 59 malignant pleural mesothelioma 59 papular 59 extracapsular extension 59 pCR 59 benign growths 59 glaucoma cataract 59 TCF#L# 59 Basal cell carcinoma 59 idiopathic myelofibrosis 59 hyperintense lesions 59 EGF receptors 59 atypical ductal hyperplasia 59 leukemias lymphomas 59 metastasis 59 histopathologic examination 59 extramedullary 59 melanocytic nevi 59 MYCN amplification 59 colonic polyps 59 androgenetic alopecia 59 sentinel nodes 59 synovial sarcoma 59 invasive carcinomas 59 hematopoietic cancers 59 unresectable tumors 59 oesophageal 59 microsatellite instability 59 recurrent laryngeal nerve 59 carcinoid tumors 59 prolonged QT interval 59 sarcoid 59 macular disease 59 ALA PDT 59 B7 H3 59 gastric cardia 59 Epstein Barr virus EBV 59 carotid plaques 59 infarcts 59 basal cell cancer 59 squamous cell carcinoma 59 pericardial effusion 59 intraductal 59 fluoroquinolone resistance 59 macular edema 59 axillary 59 lumbar disk herniation 59 Immunohistochemical analysis 59 eccrine 59 fibroadenoma 59 Synovial sarcoma 59 recurrent venous thromboembolism 59 microscopic hematuria 59 Glioma 59 malignant fibrous histiocytoma 59 EUS FNA 59 malignancies 59 repigmentation 59 pseudophakic 59 T1a 59 corneal infections 59 postoperative atrial fibrillation 59 TGF β 59 hypopigmentation 59 squamous 59 diabetic retinopathy DR 59 bronchogenic carcinoma 59 prostate cancer PCa 59 lung adenocarcinomas 59 pharyngeal cancer 59 gastrointestinal stromal tumor 59 neuroendocrine cancers 59 ovarian carcinomas 59 pT3 59 Metastases 59 GPC5 59 MGd 59 NSCLC tumors 59 baseline LDH 59 chromosomal aberrations 59 Asymptomatic 59 acute aortic dissection 59 CYT# potent vascular disrupting 59 extrahepatic 59 chronic HBV infection 59 polypoid 59 aplasia 59 epithelial cancers 59 cerebral infarction 59 cutaneous squamous cell carcinoma 59 PARP inhibition 59 benign breast 59 ABCB1 59 esophagogastric 59 Benign breast 59 precancerous lesions 59 Intussusception 59 eosinophil count 59 submandibular gland 59 trans retinoic acid 59 atheroma volume 59 poorer prognosis 59 monoclonal gammopathy 59 medically inoperable 59 occult metastases 59 proximal colon 59 axillary dissection 59 motor neuron degeneration 59 precancerous lesion 59 HPV# 59 supratentorial 59 dentinal hypersensitivity 59 HGPIN 59 bladder tumors 58 vestibular schwannomas 58 idiopathic PAH 58 antiproliferative effects 58 primary hyperparathyroidism 58 renal scarring 58 myelofibrosis polycythemia vera 58 EGFR TK 58 cervical lesions 58 colon tumors 58 underwent surgical resection 58 lesions 58 mTOR inhibitors 58 squamous carcinoma 58 nonproliferative 58 vulvar cancer 58 sonographic diagnosis 58 atrial tachyarrhythmias 58 nodal metastases 58 melanocytic 58 mitochondrial toxicity 58 pancreatic cancers 58 F FDG PET 58 periocular 58 mammographically 58 carotid stenosis 58 metastatic colorectal 58 chemoembolization 58 osteochondroma 58 cell adhesion molecule 58 carcinoma HNSCC 58 Glioblastoma multiforme GBM 58 fibroma 58 metastatic prostate cancer 58 isolated systolic hypertension 58 biochemical relapse 58 pancreatic islet cell 58 melanomas 58 nonischemic 58 radiosensitivity 58 esophageal tumors 58 ocular toxicity 58 Barrett esophagus 58 situ CIS 58 choroidal 58 colon cancers 58 intracranial aneurysms 58 lymphocytic 58 neoadjuvant therapy 58 sonographically 58 C. trachomatis 58 prostate cancers 58 OSAHS 58 lymphovascular invasion 58 Barrett Esophagus 58 hepatic fibrosis 58 cataract extraction 58 sarcomas 58 gastric corpus 58 pre cancerous lesions 58 hepatocellular carcinomas 58 carcinoma HCC 58 tumor histology 58 thrombocytopenic 58 leiomyosarcoma 58 ovarian breast 58 spontaneous regression 58 EGFR mutation 58 elevated triglyceride levels 58 BRAF V#E 58 medulloblastoma 58 QTc prolongation 58 acute myeloid 58 ipsilateral 58 distal colon 58 anatomical abnormalities 58 histologic findings 58 pseudotumor cerebri 58 Thal Dex 58 recurrent myocardial infarction 58 dexrazoxane 58 GBA mutations 58 recurrent VTE 58 SSc 58 bullous 58 glioma rarer 58 pre cancerous 58 metastatic malignant 58 chlamydial infections 58 biliary tract cancer 58 Fuchs dystrophy 58 lymphocytosis 58 retinoblastoma 58 micrometastasis 58 GSTP1 58 BRCA mutation carriers 58 CMV disease 58 epithelial ovarian 58 PTPN# 58 Leydig cells 58 enteroviral infection 58 etiologic 58 fallopian tube cancers 58 motoneurons 58 NF2 58 pathologic myopia 58 urethritis 58 lung cancers 58 severe neutropenia 58 lobular 58 peritumoral 58 pre malignant lesions 58 parotid 58 Squamous Cell Carcinoma 58 cervical intraepithelial neoplasia 58 bowel cancers 58 bile duct cancers 58 cytoreductive surgery 58 tumor metastases 58 vaso occlusive crisis 58 inherited mutations 58 fibroadenomas 58 ovarian cancers 58 cutaneous lupus 58 Sjogren syndrome 58 corneal inflammation 58 NSF NFD 58 gonococcal infection 58 rs# [002] 58 carotid plaque 58 CPVT 58 synovial tissue 58 Malignant Melanoma 58 SLNB 58 macroalbuminuria 58 mammary cancers 58 cervical carcinoma 58 colorectal cancers 58 bacterial keratitis 58 Neurofibromatosis type 58 lymphadenopathy 58 Glioblastoma Multiforme GBM 58 polyp recurrence 58 invasive candidiasis 58 presymptomatic 58 TP# mutations 58 Sezary syndrome 58 ovarian pancreatic 58 Toxicities 58 malignant neoplasms 58 bone marrow suppression 58 evaporative dry 58 biliary tract 58 histologically proven 58 noncardiac 58 metastatic cancer 58 NAFLD 58 submandibular 58 metastatic melanomas 58 plasma kallikrein 58 intravitreal bevacizumab 58 lacunar 58 S. aureus colonization 58 microvessel 58 SUVmax 58 incidentalomas 58 neoplastic diseases 58 lung adenocarcinoma 58 corneal ectasia 58 brain glucose metabolism 58 TTR gene 58 Metastatic breast cancer 58 Heavy menstrual bleeding 58 thymoma 58 aerodigestive tract 58 gadolinium enhanced 58 periorbital 58 mucosal lesions 58 metastatic lung cancer 58 MLH1 58 Adenocarcinoma 58 florbetaben 58 JAK2 enzyme 58 cerebral vasospasm 58 Barrett mucosa 58 BRCA1 BRCA2 58 TEAEs 58 urothelium 58 alanine aminotransferase ALT 58 pathologic diagnosis 58 cytogenetic abnormalities 58 corneal neovascularization 58 KRAS mutations 58 ALND 58 MSH2 58 TT genotype 58 prostate carcinomas 58 dysplastic nevi 58 cranial irradiation 58 retinal detachment 58 nonalcoholic steatohepatitis 58 perimenopausal women 58 malignant melanomas 58 T#I [002] 58 herpes simplex encephalitis 58 Carcinomas 58 vasogenic edema 58 adenomatous polyp 58 clefting 58 melanoma 58 reflux disease 58 Upregulation 58 anti angiogenic therapy 58 T2 lesions 57 Computed tomography 57 acute myelogenous leukemia AML 57 precancers 57 lymphomas leukemias 57 JMML 57 Zyclara Cream 57 hepatic steatosis 57 pancreatic endocrine 57 PNET 57 LV dysfunction 57 lymph node removal 57 cryptococcosis 57 asymptomatic carotid stenosis 57 periodontal pathogens 57 EoE 57 allergic dermatitis 57 epithelial ovarian cancer 57 MMP9 57 scintigraphic 57 PsA 57 microcalcifications 57 variceal 57 posterior uveitis 57 uvea 57 OGG1 57 cortical dysplasia 57 aneurysm rupture 57 penile cancers 57 osteoporotic vertebral compression fractures 57 axillary nodes 57 HRCT 57 HER2 positivity 57 epididymal 57 corneal edema 57 choroidal vasculopathy 57 pigmented layer 57 K ras mutations 57 brain lesions 57 cervical lymph node 57 smoldering myeloma 57 uterine tumors 57 vascular endothelial 57 inflammatory lesions 57 Acute lymphoblastic leukemia 57 preoperative chemotherapy 57 colorectal carcinomas 57 lymphoid 57 urothelial 57 thyroid cancers 57 VUR 57 total thyroidectomy 57 heterotaxy 57 pelvic malignancies 57 seliciclib 57 telomerase inhibition 57 grade gliomas 57 APOE e4 57 chromosomal rearrangement 57 thrombotic events 57 postoperative morbidity 57 thromboembolic disease 57 hyperbilirubinemia 57 serum PSA 57 variceal hemorrhage 57 HIV HCV coinfected 57 hilar 57 lymphoproliferative disorders 57 melanoma tumors 57 mastocytosis 57 Mitomycin C 57 haematopoietic 57 osteochondromas 57 peritoneal cancer 57 tumor regressions 57 PSA nadir 57 endometrial tumors 57 granulomas 57 T2DM 57 abdominal adiposity 57 atopic 57 underarm lymph nodes 57 fibrocystic changes 57 FGFR3 57 chronic GVHD 57 salivary flow 57 Relapsing remitting MS 57 Radical prostatectomy 57 uPA 57 rectal cancers 57 endometrial ovarian 57 neoplastic cells 57 ovarian lung 57 peritoneal carcinomatosis 57 osteoid osteoma 57 IDH1 57 advanced neoplasia 57 sarcosine 57 pathologic 57 Endometrial cancer 57 oropharynx 57 aminotransferases 57 PHPT 57 leukemia ALL 57 keratitis 57 tryptase 57 herpes infection 57 EBV infection 57 precancerous tumors 57 N myc 57 Uveal melanoma 57 TNF blocker therapy 57 myeloid leukemia 57 hypercalcemia 57 alpha interferons 57 opacification 57 HNPCC 57 choriocarcinoma 57 DFMO 57 chromosomal instability 57 benign proliferative breast 57 cyclin E 57 CMV retinitis 57 trigeminal ganglia 57 trophoblast cells 57 pilocytic astrocytomas 57 breast lesions 57 nevus 57 resectable 57 reinfarction 57 basal cell 57 astrocytoma 57 photodamage 57 comedones 57 PSADT 57 CC genotype 57 confidence interval #.#-#.# 57 contralateral breast 57 bullous pemphigoid 57 desmoplastic 57 incisional hernias 57 leukoencephalopathy 57 tumorigenicity 57 radiosensitive 57 Glioblastoma 57 tumorous 57 TOP2A 57 adjuvant radiation 57 granulomatous 57 thyrotoxicosis 57 cytoreduction 57 low expressors 57 herpes zoster 57 fallopian tube carcinoma 57 EGFR inhibitors 57 gastrointestinal stromal tumors GISTs 57 intracranial hemorrhage ICH 57 JAK STAT signaling 57 systemic amyloidosis 57 bexarotene 57 GBMs 57 myelomas 57 calculi 57 wedge resection 57 primary biliary cirrhosis 57 systemic toxicity 57 neuritic 57 subconjunctival hemorrhage 57 radiographic findings 57 non squamous NSCLC 57 cervical vaginal 57 iritis 57 trabeculectomy 57 cystic lesions 57 explants 57 hypervascular tumors 57 ApoE4 57 glomerular filtration 57 associated lymphoid tissue 57 thyroid tumors 57 cancer mCRC 57 fetal chromosomal 57 myeloproliferative disorders 57 erythema nodosum 57 glycated hemoglobin levels 57 Metastatic colorectal cancer 57 Metastatic 57 intrauterine infection 57 giant cell arteritis 57 untreated metastatic melanoma 57 sclerosing 57 malignant lesion 57 Retinoblastoma 57 cervical dysplasia 57 EGFR mutant 57 nonhereditary 57 posterior fossa 57 infiltrating ductal carcinoma 57 Genetic variants 57 upper GI tract 57 seminal vesicle invasion 57 ADAMTS# 57 colorectal liver metastases 57 PDGFR 57 Glioblastomas 57 Gleevec resistant 57 subclinical hypothyroidism 57 transfusion syndrome 57 androgen deprivation 57 cataract formation 57 neurologic complications 57 cerebral microbleeds 57 chronic prostatitis 57 NF kappaB activation 57 DSAEK 57 antitumor effect 57 ovarian tumors 57 complement inhibitor eculizumab 57 bacterium Neisseria meningitidis 57 keloid 57 myeloproliferative 57 denervation 57 somatic mutations 57 upper gastrointestinal bleeding 57 retroperitoneal 57 nonvertebral fracture 57 intestinal polyps 57 blepharospasm 57 conjunctivitis pink 57 adenoidectomy